Publication|Articles|July 8, 2024

Supplements and Featured Publications

  • Breaking the Cycle of Dry Eye Disease: Evidence for Cyclosporine Ophthalmic Solution, 0.09%

Breaking the Cycle of Dry Eye Disease: Evidence for Cyclosporine Ophthalmic Solution, 0.09%

This clinical brief provides a background on DED and reviews DED treatment and challenges associated with prescription eye drops.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs
Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

View more
Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care
AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

View more
Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text